Latest Breaking News On - Translational research in transplantation - Page 1 : comparemela.com

OSE Immunotherapeutics Announces Peer-Reviewed Publication on Novel Myeloid Immune Checkpoint CLEC-1 in Journal of Immunology

OSE Immunotherapeutics Announces Peer-Reviewed Publication on Novel Myeloid Immune Checkpoint CLEC-1in Journal of Immunology Nantes, France – April 2, 2024 – 7:30 am CET – OSE.

Nicolas poirierVanessa gauttierCamille ligeronElise chiffoleauBenoni goullinMarion drouinFlorence portejoieKate barretteEmmanuelle wilhelmBerangere evrardEmmanuel merieauKevin biteauJavier saenzIrene baccelliCaroline maryNantes university at hospital

OSE Immunotherapeutics SA: OSE Immunotherapeutics Presents Update on BiCKIIL-7, CLEC-1 and OSE-230 Preclinical Programs in Immuno-Oncology and Immuno-Inflammation At International Conferences

OSE Immunotherapeutics SA: OSE Immunotherapeutics Presents Update on BiCKIIL-7, CLEC-1 and OSE-230 Preclinical Programs in Immuno-Oncology and Immuno-Inflammation At International Conferences
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Noord hollandUnited statesFlorence portejoieVanessa gauttierElise chiffoleauNicolas poirierDifferent possibilities for the development of cytokineVeloxis pharmaceuticals incHead of researchNantes university at hospitalTranslational research in transplantationBoehringer ingelheimDrug development summitNantes university hospitalRegulatory newsAntibody engineering therapeutics europe

OSE Immunotherapeutics Presents Update on BiCKI®IL-7, CLEC-1 and OSE-230 Preclinical Programs in Immuno-Oncology and Immuno-Inflammation At International Conferences

NANTES, France (BUSINESS WIRE) Jun 15, 2023

United statesNoord hollandElise chiffoleauVanessa gauttierNicolas poirierFlorence portejoieTranslational research in transplantationNantes university hospitalNantes university at hospitalBoehringer ingelheimDrug development summitVeloxis pharmaceuticals incHead of researchAntibody engineeringTherapeutics europeAnnual cytokine based drug development summit

OSE Immunotherapeutics Announces Publication of Peer-Reviewed Data on CLEC-1, its Novel Myeloid Immune Checkpoint in Science Advances

Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (Paris:OSE) today announced the publication of data in the peer-reviewed journal Science Advances on a first-in-classpreclinical

France generalSabrina pengamDebajyoti sinhaCedric louvetIsabelle giraultVanessa gauttierMaria dolores lopezJavier saenzNicolas poirierVirginie thepenierEmmanuelle wilhelmThomas guillotCaroline maryCamille ligeronEmmanuel merieauAriane desselle